logo

For the Inventor, By the Inventor

Canterbury, United Kingdom

Michael J Fray

USPTO Granted Patents = 19

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 135(Granted Patents)


Location History:

  • Wingham, Nr. Canterbury, GB (1989)
  • Kent, GB (1989)
  • Deal, GB (1990)
  • Canterbury, GB (1989 - 1992)
  • Nr. Canterbury, GB (1991 - 1993)
  • Wingham, GB (1994)
  • Sandwich, GB (1998 - 2008)

Company Filing History:

goldMedal19 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1989-2008

Loading Chart...
19 patents (USPTO):Explore Patents
1. 7378436 - Compounds (2008-05-27),
2. 6936619 - Quinazolinone compounds useful in therapy (2005-08-30),
3. 6376490 - Quinoxalinediones (2002-04-23),
4. 6350907 - Matrix metalloprotease inhibitors (2002-02-26),
5. 6015825 - Triazole antifungal agents (2000-01-18),
6. 5852016 - Quinoxaline derivatives useful in therapy (1998-12-22),
7. 5783572 - Quinoxalinedione NMDA receptor antagonists (1998-07-21),
8. 5322847 - Azabenzimidazoles in the treatment of asthma, arthritis and related (1994-06-21),
9. 5214044 - 1,4-dihydropyridines useful as pharmaceuticals (1993-05-25),
10. 5149814 - Alkyl 2-benzylidene-4-(2-alkylimidazopyrid-1-yl) benzoylacetate esters (1992-09-22),
11. 5120747 - Platelet activating factor antagonists (1992-06-09),
12. 5070205 - Alkyl 2-benzylidene-4-(benzimidazol-1-yl) benzoylacetate esters as (1991-12-03),
13. 5008263 - Diazepine antiallergy agents (1991-04-16),
14. 4992447 - Certain oxo-pyrrolo 1,4-dihydropyridines as antiallergy and (1991-02-12),
15. 4963560 - 1,4-dihydropyridine derivatives (1990-10-16),

Title: **Michael J Fray: Innovator in Pharmaceutical Compounds**

Introduction

Michael J Fray is a distinguished inventor based in Canterbury, GB, renowned for his significant contributions to the field of pharmaceutical science. With an impressive portfolio of 19 patents, he plays a vital role in advancing therapeutic compounds, particularly in addressing critical health issues.

Latest Patents

Among his latest innovations, Fray has developed compounds that serve as serotonin and noradrenaline re-uptake inhibitors. These compounds are characterized by a complex chemical formula (I), which details various structurally diverse moieties such as Calkyl, aryl, and cycloalkyl groups. The versatility of these compounds allows for potential applications in therapeutic areas, including the treatment of urinary incontinence. His ongoing research continues to explore the pharmacological utility of quinazolinone compounds, which further underscores his influence in pharmaceuticals.

Career Highlights

Fray's career is marked by his affiliation with Pfizer Corporation, a leading pharmaceutical company where he contributes his expertise in drug development. His innovative mindset and dedication to research have propelled him to the forefront of pharmaceutical inventions, leading to multiple patents that address both current and emerging health concerns.

Collaborations

Throughout his career, Michael J Fray has collaborated with notable colleagues, including Kelvin Cooper and Kenneth Richardson. These collaborations have facilitated a dynamic exchange of ideas and expertise, fostering innovation within the realm of pharmaceutical invention.

Conclusion

Michael J Fray stands out as an influential inventor whose work at Pfizer Corporation has significantly advanced the field of pharmacology. His 19 patents embody his relentless pursuit of new therapeutic solutions, highlighting his valuable contribution to health sciences and proving the impactful role of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…